vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and IPG PHOTONICS CORP (IPGP). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $274.5M, roughly 1.0× IPG PHOTONICS CORP). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 4.8%, a 91.5% gap on every dollar of revenue. On growth, IPG PHOTONICS CORP posted the faster year-over-year revenue change (17.1% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 4.4%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
ACAD vs IPGP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $274.5M |
| Net Profit | $273.6M | $13.3M |
| Gross Margin | 90.8% | 36.1% |
| Operating Margin | 6.1% | 1.2% |
| Net Margin | 96.3% | 4.8% |
| Revenue YoY | 9.4% | 17.1% |
| Net Profit YoY | 90.3% | 69.8% |
| EPS (diluted) | $1.61 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $274.5M | ||
| Q3 25 | $278.6M | $250.8M | ||
| Q2 25 | $264.6M | $250.7M | ||
| Q1 25 | $244.3M | $227.8M | ||
| Q4 24 | $259.6M | $234.3M | ||
| Q3 24 | $250.4M | $233.1M | ||
| Q2 24 | $242.0M | $257.6M | ||
| Q1 24 | $205.8M | $252.0M |
| Q4 25 | $273.6M | $13.3M | ||
| Q3 25 | $71.8M | $7.5M | ||
| Q2 25 | $26.7M | $6.6M | ||
| Q1 25 | $19.0M | $3.8M | ||
| Q4 24 | $143.7M | $7.8M | ||
| Q3 24 | $32.8M | $-233.6M | ||
| Q2 24 | $33.4M | $20.2M | ||
| Q1 24 | $16.6M | $24.1M |
| Q4 25 | 90.8% | 36.1% | ||
| Q3 25 | 92.2% | 39.5% | ||
| Q2 25 | 92.2% | 37.3% | ||
| Q1 25 | 91.7% | 39.4% | ||
| Q4 24 | 91.6% | 38.6% | ||
| Q3 24 | 92.5% | 23.2% | ||
| Q2 24 | 92.5% | 37.3% | ||
| Q1 24 | 88.8% | 38.7% |
| Q4 25 | 6.1% | 1.2% | ||
| Q3 25 | 12.8% | 3.1% | ||
| Q2 25 | 12.2% | 0.0% | ||
| Q1 25 | 7.9% | 0.8% | ||
| Q4 24 | 59.1% | 6.0% | ||
| Q3 24 | 12.6% | -108.7% | ||
| Q2 24 | 12.6% | 4.7% | ||
| Q1 24 | 7.4% | 7.6% |
| Q4 25 | 96.3% | 4.8% | ||
| Q3 25 | 25.8% | 3.0% | ||
| Q2 25 | 10.1% | 2.6% | ||
| Q1 25 | 7.8% | 1.6% | ||
| Q4 24 | 55.4% | 3.3% | ||
| Q3 24 | 13.1% | -100.2% | ||
| Q2 24 | 13.8% | 7.8% | ||
| Q1 24 | 8.0% | 9.6% |
| Q4 25 | $1.61 | $0.30 | ||
| Q3 25 | $0.42 | $0.18 | ||
| Q2 25 | $0.16 | $0.16 | ||
| Q1 25 | $0.11 | $0.09 | ||
| Q4 24 | $0.86 | $0.27 | ||
| Q3 24 | $0.20 | $-5.33 | ||
| Q2 24 | $0.20 | $0.45 | ||
| Q1 24 | $0.10 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $839.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $2.1B |
| Total Assets | $1.6B | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $839.3M | ||
| Q3 25 | $258.0M | $870.4M | ||
| Q2 25 | $253.6M | $899.6M | ||
| Q1 25 | $217.7M | $926.9M | ||
| Q4 24 | $319.6M | $930.2M | ||
| Q3 24 | $155.1M | $1.0B | ||
| Q2 24 | $177.1M | $1.1B | ||
| Q1 24 | $204.7M | $1.1B |
| Q4 25 | $1.2B | $2.1B | ||
| Q3 25 | $917.3M | $2.1B | ||
| Q2 25 | $822.4M | $2.1B | ||
| Q1 25 | $765.2M | $2.1B | ||
| Q4 24 | $732.8M | $2.0B | ||
| Q3 24 | $577.2M | $2.1B | ||
| Q2 24 | $516.7M | $2.3B | ||
| Q1 24 | $464.0M | $2.3B |
| Q4 25 | $1.6B | $2.4B | ||
| Q3 25 | $1.3B | $2.4B | ||
| Q2 25 | $1.2B | $2.4B | ||
| Q1 25 | $1.1B | $2.3B | ||
| Q4 24 | $1.2B | $2.3B | ||
| Q3 24 | $976.9M | $2.4B | ||
| Q2 24 | $914.1M | $2.5B | ||
| Q1 24 | $855.1M | $2.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $28.8M |
| Free Cash FlowOCF − Capex | — | $10.9M |
| FCF MarginFCF / Revenue | — | 4.0% |
| Capex IntensityCapex / Revenue | — | 6.5% |
| Cash ConversionOCF / Net Profit | -0.18× | 2.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-3.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $28.8M | ||
| Q3 25 | $74.3M | $35.3M | ||
| Q2 25 | $64.0M | $-2.2M | ||
| Q1 25 | $20.3M | $13.4M | ||
| Q4 24 | $40.4M | $73.8M | ||
| Q3 24 | $63.2M | $66.1M | ||
| Q2 24 | $25.0M | $53.5M | ||
| Q1 24 | $29.1M | $54.6M |
| Q4 25 | — | $10.9M | ||
| Q3 25 | $73.9M | $14.6M | ||
| Q2 25 | — | $-17.6M | ||
| Q1 25 | — | $-11.4M | ||
| Q4 24 | — | $50.6M | ||
| Q3 24 | $63.2M | $43.0M | ||
| Q2 24 | — | $29.2M | ||
| Q1 24 | — | $26.5M |
| Q4 25 | — | 4.0% | ||
| Q3 25 | 26.5% | 5.8% | ||
| Q2 25 | — | -7.0% | ||
| Q1 25 | — | -5.0% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | 25.2% | 18.4% | ||
| Q2 24 | — | 11.3% | ||
| Q1 24 | — | 10.5% |
| Q4 25 | — | 6.5% | ||
| Q3 25 | 0.1% | 8.3% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | 0.0% | 9.9% | ||
| Q2 24 | — | 9.4% | ||
| Q1 24 | — | 11.1% |
| Q4 25 | -0.18× | 2.17× | ||
| Q3 25 | 1.03× | 4.73× | ||
| Q2 25 | 2.40× | -0.34× | ||
| Q1 25 | 1.07× | 3.58× | ||
| Q4 24 | 0.28× | 9.44× | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | 2.65× | ||
| Q1 24 | 1.76× | 2.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
IPGP
| Materials Processing | $232.8M | 85% |
| Laser And Non Laser Systems | $38.8M | 14% |
| Transferred Over Time | $5.3M | 2% |
